Pharmaceutical maker Jubilant Pharmova, wholly owned subsidiary Jubilant Pharma Limited, through one of its wholly owned subsidiaries, Jubilant HollisterStier General Partnership, will invest $76.6 ...

NOIDA, India & SPOKANE, Wash., Oct. 10, 2025 /PRNewswire/ -- Jubilant Pharmova Limited announced today that Jubilant HollisterStier LLC (JHS)—a wholly owned subsidiary and a leading North American ...

Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, and a global CRDMO operating from five sites across India and Europe, – announced the opening of a new discovery and ...

Jubilant HollisterStier, a CDMO unit of Singapore’s Jubilant Pharma, plans to spend (PDF) $76 million to expand its Montreal facility. The project will double the plant’s drug production capacity. The ...

SALISBURY, MD - Pharmaceutical company Jubilant Cadista’s parent company Jubilant Pharmova has announced the upcoming closure of manufacturing operations at their Salisbury facility. In a release ...

YARDLEY, Pa.--(BUSINESS WIRE)--Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manufacturing facilities ...

On Thursday, Jubilant Pharmova, the parent company of Salisbury's Jubilant Cadista Pharmaceuticals Inc., announced plans to close its location permanently on June 17. Before layoffs in 2022, Jubilant ...

The CDMO-API business that is involved in the manufacturing of Active Pharmaceutical Ingredients. Jubilant Therapeutics is involved in the Proprietary Novel Drugs business and is an innovative ...